Examkin

Question

Difficulty: MediumMenstrual Cycle Abnormalities and Contraception

A 39-year-old woman comes to the clinic reporting heavy, continuous vaginal bleeding for the past 18 days. She states that her menstrual cycles have been highly unpredictable since menarche, typically occurring every 3 to 6 months. Over the last two years, she has gained 15 kg (33 lbs). She also notes increased facial hair growth for which she occasionally uses laser hair removal. Her medical history includes type 2 diabetes mellitus, which is managed with metformin. She does not use any contraception. Her temperature is 37.0°C (98.6°F), blood pressure is 132/84 mmHg, pulse is 82/min, and respirations are 14/min. Her BMI is 38 kg/m². Pelvic examination reveals normal external genitalia. The vagina contains dark red blood. The uterus is normal in size, smooth, and mobile. No adnexal masses are palpated. A urine pregnancy test is negative. Which of the following is the most appropriate next step in the management of this patient?

  1. Endometrial biopsyAnswer
  2. B
    Pelvic ultrasound
  3. C
    Prescription of combination oral contraceptives
  4. D
    Measurement of serum testosterone and dehydroepiandrosterone sulfate
  5. E
    Measurement of serum thyroid-stimulating hormone

Answer

Endometrial biopsy
The correct answer is endometrial biopsy. This patient is experiencing abnormal uterine bleeding (AUB). The initial evaluation of AUB must always include ruling out pregnancy, which has been done. The next critical step is to determine the need for endometrial sampling. According to clinical guidelines, an endometrial biopsy is indicated in all women aged 45 years and older with AUB. However, it is also strictly indicated in women under 45 years of age if they have significant risk factors for endometrial hyperplasia or malignancy. These risk factors primarily relate to prolonged exposure to unopposed estrogen, which typically occurs in the setting of chronic anovulation (e.g., polycystic ovary syndrome) and obesity (due to the peripheral conversion of androgens to estrogens by adipose tissue). This patient is 39 years old but has a classic history for PCOS (irregular menses since menarche, hirsutism), severe obesity, and type 2 diabetes mellitus, placing her at high risk for endometrial hyperplasia. Therefore, obtaining a tissue diagnosis via endometrial biopsy is the most appropriate next step to definitively rule out malignancy before any further workup or treatment is initiated.

Step-by-Step Solution

1
Identify the primary clinical problem.
The patient is a 39-year-old premenopausal woman presenting with prolonged, heavy abnormal uterine bleeding (AUB).
Establishing the chief complaint and demographic profile guides the initial diagnostic algorithm.
2
Evaluate for risk factors associated with endometrial hyperplasia or malignancy.
The patient has significant risk factors for unopposed estrogen exposure, including chronic anovulation (irregular menses, hirsutism), severe obesity, and type 2 diabetes mellitus.
The presence of these risk factors alters the standard evaluation pathway for premenopausal women under 45 years of age.
3
Determine the most appropriate initial diagnostic intervention based on risk stratification.
An endometrial biopsy must be performed prior to relying on imaging or initiating medical therapy.
Clinical guidelines mandate tissue sampling in women under 45 with AUB who have risk factors for unopposed estrogen to definitively rule out endometrial carcinoma.

Key Concept

In premenopausal women under age 45 with abnormal uterine bleeding, an endometrial biopsy is indicated if they possess risk factors for endometrial hyperplasia or cancer, such as obesity and chronic anovulation.
Rate this question

Topics

Menstrual Cycle Abnormalities and Contraception

More questions from this topic